Ascenion is an IP asset management company focused on the life sciences and 100% subsidiary of the LifeScience Foundation for the Promotion of Science and Research. Ascenion works closely with public research institutions to ensure that promising scientific findings are identified, secured and brought to market to the benefit of society. Ascenion is exclusive technology transfer partner to numerous research institutes of the Helmholtz and Leibniz Associations, the Hanover Medical School and associated organizations for translational research and offers industry more than 750 commercial opportunities. On average, Ascenion’s interdisciplinary team evaluates 100 invention disclosures per year, handles 70 patent applications and negotiates some 80 revenue-generating cooperation and licensing agreements with industry. Among Ascenion′s particular strengths are start-up coaching and active investment management.